131 related articles for article (PubMed ID: 23303644)
21. Effect of three-drug delivery modalities on olfactory function in chronic sinusitis.
Reychler G; Colbrant C; Huart C; Le Guellec S; Vecellio L; Liistro G; Rombaux P
Laryngoscope; 2015 Mar; 125(3):549-55. PubMed ID: 25224684
[TBL] [Abstract][Full Text] [Related]
22. [Research on the laser atomization treatment machine].
Jiang BS; Tian RZ; Zhang L
Zhongguo Yi Liao Qi Xie Za Zhi; 2005 Jul; 29(5):366-7. PubMed ID: 16419948
[TBL] [Abstract][Full Text] [Related]
23. Recent In Vitro and In Silico Advances in the Understanding of Intranasal Drug Delivery.
Chen J; Martin AR; Finlay WH
Curr Pharm Des; 2021; 27(12):1482-1497. PubMed ID: 33183191
[TBL] [Abstract][Full Text] [Related]
24. Assessment of the influence factors on nasal spray droplet velocity using phase-Doppler anemometry (PDA).
Liu X; Doub WH; Guo C
AAPS PharmSciTech; 2011 Mar; 12(1):337-43. PubMed ID: 21286880
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of different parameters that affect droplet-size distribution from nasal sprays using the Malvern Spraytec.
Dayal P; Shaik MS; Singh M
J Pharm Sci; 2004 Jul; 93(7):1725-42. PubMed ID: 15176062
[TBL] [Abstract][Full Text] [Related]
26. Establishing quantitative relationships between changes in nasal spray in vitro metrics and drug delivery to the posterior nasal region.
Kolanjiyil AV; Walenga R; Babiskin A; Golshahi L; Hindle M; Longest W
Int J Pharm; 2023 Mar; 635():122718. PubMed ID: 36781083
[TBL] [Abstract][Full Text] [Related]
27. Delivery of Agarose-aided Sprays to the Posterior Nose for Mucosa Immunization and Short-term Protection against Infectious Respiratory Diseases.
Seifelnasr A; Talaat M; Si XA; Xi J
Curr Pharm Biotechnol; 2024; 25(6):787-798. PubMed ID: 37533243
[TBL] [Abstract][Full Text] [Related]
28. Latest advances in nasal drug-delivery technology.
Bommer R
Med Device Technol; 1999 May; 10(4):22-8. PubMed ID: 10539106
[TBL] [Abstract][Full Text] [Related]
29. Effect of formulation- and administration-related variables on deposition pattern of nasal spray pumps evaluated using a nasal cast.
Kundoor V; Dalby RN
Pharm Res; 2011 Aug; 28(8):1895-904. PubMed ID: 21499839
[TBL] [Abstract][Full Text] [Related]
30. Characterization of nasal spray pumps and deposition pattern in a replica of the human nasal airway.
Cheng YS; Holmes TD; Gao J; Guilmette RA; Li S; Surakitbanharn Y; Rowlings C
J Aerosol Med; 2001; 14(2):267-80. PubMed ID: 11681658
[TBL] [Abstract][Full Text] [Related]
31. Deposition pattern of nasal sprays in man.
Newman SP; Morén F; Clarke SW
Rhinology; 1988 Jun; 26(2):111-20. PubMed ID: 3175455
[TBL] [Abstract][Full Text] [Related]
32. The influence of actuation parameters on in vitro testing of nasal spray products.
Guo C; Doub WH
J Pharm Sci; 2006 Sep; 95(9):2029-40. PubMed ID: 16865693
[TBL] [Abstract][Full Text] [Related]
33. Validation and Sensitivity analysis for a nasal spray deposition computational model.
Calmet H; Oks D; Santiago A; Houzeaux G; Corfec AL; Deruyver L; Rigaut C; Lambert P; Haut B; Goole J
Int J Pharm; 2022 Oct; 626():122118. PubMed ID: 36029992
[TBL] [Abstract][Full Text] [Related]
34. Nasal airway resistance after decongestion with a nasal spray or a bellows device.
Jessen M; Ivarsson A; Malm L
Rhinology; 1996 Mar; 34(1):28-31. PubMed ID: 8739865
[TBL] [Abstract][Full Text] [Related]
35. Investigation and comparison of performance of effervescent and standard pneumatic atomizer intended for soluble aqueous coating.
Nielsen AF; Poul B; Kristensen HG; Kristensen J; Hovgaard L
Pharm Dev Technol; 2006; 11(2):243-53. PubMed ID: 16749535
[TBL] [Abstract][Full Text] [Related]
36. Analgesic effects of intranasal butorphanol tartrate administered via a unit-dose device in the dental impaction pain model: a randomized, double-blind, placebo-controlled, parallel-group study.
Wermeling DP; Grant GM; Lee A; Alexander N; Rudy AC
Clin Ther; 2005 Apr; 27(4):430-40. PubMed ID: 15922816
[TBL] [Abstract][Full Text] [Related]
37. The need for and development of a single use disposable nasal spray.
Coakley JF; Arthurs GJ; Wilsher TK
J Laryngol Otol; 1993 Jan; 107(1):20-3. PubMed ID: 8445304
[TBL] [Abstract][Full Text] [Related]
38. Intermittent aerosol delivery to the lungs during high-flow nasal cannula therapy.
Golshahi L; Longest PW; Azimi M; Syed A; Hindle M
Respir Care; 2014 Oct; 59(10):1476-86. PubMed ID: 24917454
[TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of a novel nasal spray for maxillary dental anesthesia.
Ciancio SG; Hutcheson MC; Ayoub F; Pantera EA; Pantera CT; Garlapo DA; Sobieraj BD; Almubarak SA
J Dent Res; 2013 Jul; 92(7 Suppl):43S-8S. PubMed ID: 23690356
[TBL] [Abstract][Full Text] [Related]
40. In Vitro Assessment of Spray Deposition Patterns in a Pediatric (12 Year-Old) Nasal Cavity Model.
Sawant N; Donovan MD
Pharm Res; 2018 Mar; 35(5):108. PubMed ID: 29582159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
